Urology

sponsor

Your Unread Messages

Hello, Suzanne Dixon
Manage E-mail  |  Logout
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Moore A et al. – Testicular cancer is the most common malignancy in men aged 15–35 years and predominantly occurs at a time in a man's life when important decisions about marriage, starting a family and a professional career are being made. While treatments for testicular cancer are very successful, they can have a major impact on the person's sexuality and sense of self. The focus of this article is on exploring the impact of cancer treatments for testicular cancer on men's sexuality and how nurses can respond to their concerns in a sensitive and informed manner.


Today in Oncology...keeping you current

Is statin use associated with prostate cancer aggressiveness
BJU International, 11/09/09

Risk of dying from prostate cancer in men randomized to screening
Cancer, 10/13/09

Randomized phase III trial on gemcitabine versus mytomicin in recurrent superficial bladder cancer: Evaluation of efficacy and tolerance
Journal of Clinical Oncology, 10/26/09

Today in Testis/Scrotum...keeping you current

Is the Fowler-Stephens procedure still indicated for the treatment of nonpalpable intraabdominal testis
Journal of Pediatric Surgery, 11/04/09

Effects of grade 1 varicocele detected in the pediatric age-group on testicular development
Journal of Pediatric Surgery, 11/04/09

Health-related quality of life in long-term survivors of testicular cancer
Journal of Clinical Oncology, 11/02/09

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address